Technology

Posted on June 13, 2019 by staff

HealthTech innovator Zava secures $32m investment

Technology

HealthTech firm Zava has secured $32 million investment to roll its telemedicine platform out around Europe.

Zava connects patients with a doctor in minutes online and says its mission is to build healthcare that is accessible, dependable and a fraction of today’s cost.

The London-based company featured on our ‘101 HealthTech Innovators’ list this week and has delivered more than three million paid consultations to date.

Every month almost 100,000 patients access Zava from the UK, Germany, France, Austria, Switzerland and Ireland to seek advice, tests or treatment for a growing range of conditions.

The Series A investment led by private equity firm HPE Growth comes ahead of its launch into statutory healthcare systems in the UK, Germany and France.

“In a world of an ageing population and rising costs, healthcare systems are at a breaking point,” said David Meinertz, Zava co-founder and CEO.

“Barriers are put in people’s way and stop them getting the support they need. Zava exists to break down these barriers – costs, access & information – enabling people to do more of what matters to them.

“We’re pleased that our new partners at HPE Growth share that great ambition.”

Zava will use the investment to further accelerate its growth including building out its world class team in order to expand its medical offering and reach its ambition of becoming the world’s leading digital healthcare provider.

The funding will also help to expand Zava’s business in existing markets and to grow pan-European and then globally.

Harry Dolman, partner at HPE Growth, added: “Zava offers a unique and highly scalable model to deliver a more convenient healthcare experience to patients while radically improving the efficiency of healthcare professionals, enabling healthcare systems to reduce the overall costs associated with primary care.

“We are excited to be working with David and his team to expand Zava into statutory healthcare systems and bring Zava in a first step to the rest of Europe.”